A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.


Updates from The Motley Fool

Latest updates on United Therapeutics from Fool.com.


Stock Performance

UTHR vs. S&P 500 | 2 Year Performance
View Interactive UTHR Charts
Sponsored by

Key Data Points

Primary metrics and data points about United Therapeutics.
Current Price: $129.64
Prev Close: $129.45
Open: $129.92
Bid: $121.69
Ask: $129.80
Day's Range: $128.73 - $130.55
52wk Range: $97.52 - $164.04
Volume: 492,988
Avg Vol 515,630
Market Cap: $5.92B
P/E (ttm): 10.18
EPS (ttm): $12.72
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about United Therapeutics.
CAPS Rating 5 out of 5
 
268 Outperform
16 Underperform
CAPS All Stars
 
69 Outperform
4 Underperform

How do you think United Therapeutics will perform against the market?



You pick for United Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Martine A. Rothblatt, CEO

100% Approve

Based on 32 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for United Therapeutics.

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers